We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Advertisement
Product
Advertisement
Sino Biological Inc logo

Therapeutic Targets for Neurodegenerative Diseases

Therapeutic Targets for Neurodegenerative Diseases


Advertisement
Sino Biological Inc logo

Neurodegeneration is a neurological disorder with evolving atrophy and irreversible damage of neurons. Alzheimer's (AD) and Parkinson's (PD) are two of the most common neurodegenerative diseases. GDNF, NGF, and BDNF are growth factors responsible for the survival, maintenance, and regeneration of specific neurons, rendering them as therapeutics for neurodegenerative diseases.

Clinical trials of GDNF (therapy for PD), NGF (therapeutic option for AD), and BDNF (therapeutic target for both AD and PD) are in progress. Therapies targeting neurotrophic factors and associated receptors can also be an effective approach for the less common neurodegenerative diseases such as Huntington's (HD), amyotrophic lateral sclerosis (ALS), and Rett Syndrome.

Sino Biological has developed a panel of high-quality recombinant GDNF, NGF, and BDNF to support the research for neurodegenerative diseases.